Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-16

Clinical Trial Update: A Phase 1b Trial in Patients With Renal Cell Cancer [Phase 1]

View source ↗

Summary

Phase 1b trial in patients with metastatic renal cell cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eli Lilly and Company | Conditions: Metastatic Renal Cell Cancer | Phase 1 | Status: COMPLETED | Results posted: 2018-10-16